Ivan G. Bodis-wollner

Ivan G. Bodis-wollner's AcademicInfluence.com Rankings

Philosophy

#8485

World Rank

#11875

Historical Rank

Logic

#5514

World Rank

#6919

Historical Rank

philosophy Degrees

Ivan G. Bodis-wollner

Biology

#11488

World Rank

#14888

Historical Rank

Neuroscience

#1864

World Rank

#1920

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Ivan G. Bodis-wollner's Degrees

Doctorate Medicine University of Vienna
PhD Neurophysiology University of Vienna

Why Is Ivan G. Bodis-wollner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ivan G. Bodis-wollner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Measurements of visual evoked potentials in Parkinson's disease. (1978) (335)
Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients (1990) (296)
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. (2014) (294)
Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. (1987) (268)
Inner retinal layer thinning in Parkinson disease. (2009) (252)
Visual Acuity and Contrast Sensitivity in Patients with Cerebral Lesions (1972) (203)
Abnormalities of central contrast sensitivity in glaucoma. (1979) (202)
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. (2015) (178)
The measurement of spatial contrast sensitivity in cases of blurred vision associated with cerebral lesions. (1976) (163)
Dopaminergic deficiency and delayed visual evoked potentials in humans (1982) (151)
Visual association cortex and vision in man: pattern-evoked occipital potentials in a blind boy. (1977) (140)
α‐synuclein in the inner retina in parkinson disease (2014) (135)
Retinopathy in Parkinson disease (2009) (134)
Pattern electroretinograms and visual-evoked potentials in glaucoma and multiple sclerosis. (1983) (127)
Cortical binocularity in infants (1980) (124)
Neuropsychological and perceptual defects in Parkinson's disease. (2003) (122)
Contrast sensitivity in retinal disease. (1980) (121)
The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. (1996) (111)
The visual system in Parkinson's disease. (1993) (108)
Functional MRI mapping of occipital and frontal cortical activity during voluntary and imagined saccades (1997) (100)
The push–pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram. (1998) (98)
Recommended standards for electroretinograms and visual evoked potentials. Report of an IFCN committee. (1993) (97)
Visual evoked potentials and the visuogram in multiple sclerosis (1979) (95)
Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. (1988) (92)
Cortical activation patterns during voluntary blinks and voluntary saccades (1999) (86)
Flash and pattern electroretinograms in normal and laser-induced glaucomatous primate eyes. (1986) (83)
A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. (1994) (82)
Dopaminergic deficiency causes delayed visual evoked potentials in rats (1982) (81)
Interocular comparison of contrast sensitivities in glaucoma patients and suspects. (1980) (79)
Signs of early damage in glaucomatous monkey eyes: low spatial frequency losses in the pattern ERG and VEP. (1988) (78)
Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease (2013) (78)
Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson’s disease (PD) (2015) (77)
Visual contrast sensitivity (1988) (77)
Remodeling of the fovea in Parkinson disease (2011) (74)
Interocular Asymmetry of Foveal Thickness in Parkinson Disease (2012) (72)
Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. (1988) (67)
Foveal vision is impaired in Parkinson's disease. (2013) (67)
Temporal frequency-dependent vep changes in Parkinson's disease (1986) (64)
Flicker threshold and pattern VEP latency in ocular hypertension and glaucoma. (1983) (62)
Functional properties of sub-bands of oscillatory brain waves to pattern visual stimulation in man (2000) (62)
The effect of blur and contrast on VEP latency: comparison between check and sinusoidal and grating patterns. (1987) (60)
Visual evoked potentials in macular disease. (1985) (57)
Electrophysiological and Psychophysical Responses to Modulation of Contrast of a Grating Pattern (1972) (57)
Venturing into the no‐man's land of the retina in Parkinson's disease (2014) (55)
Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing. (1996) (54)
Detection of Visual Defects Using the Contrast Sensitivity Function (1980) (53)
VEPs in humans reveal high and low spatial contrast mechanisms. (1984) (52)
Contrast sensitivity and glare testing in the evaluation of anterior segment disease (1990) (51)
Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates (1991) (50)
Dopaminergic mechanisms in vision (1988) (50)
Vulnerability of spatial frequency channels in cerebral lesions (1976) (49)
A short latency cortical component of the foveal VEP is revealed by hemifield stimulation. (1992) (47)
Visuospatial orientation in Parkinson's disease. (1990) (47)
Visual evoked potential diagnosis of field defects in patients with chiasmatic and retrochiasmatic lesions. (1982) (46)
P300-like potentials in the normal monkey using classical conditioning and an auditory 'oddball' paradigm. (1986) (46)
Visuo-cognitive dysfunctions in Parkinson's disease. (1998) (46)
The importance of stimulus selection in VEP practice: the clinical relevance of visual physiology (1986) (46)
Alterations in event-related potentials (ERPs) of MPTP-treated monkeys. (1988) (46)
Pioglitazone in early Parkinson's disease (2015) (45)
Visual Electrophysiology in Parkinson's Disease: PERG, VEP and Visual P300 (1997) (43)
SYSTEM DISEASES AND VISUAL EVOKED POTENTIAL DIAGNOSIS IN NEUROLOGY: CHANGES DUE TO SYNAPTIC MALFUNCTION * (1980) (42)
A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease. (2016) (42)
American Electroencephalographic Society Guidelines for Writing Clinical Evoked Potential Reports (1991) (38)
On the separability of two mechanisms involved in the detection of grating patterns in humans. (1979) (37)
Recovery from cerebral blindness: evoked potential and psychophysical measurements. (1977) (37)
Nitrous oxide (1986) (35)
Generators of visually evoked neuromagnetic responses. Spatial-frequency segregation and evidence for multiple sources. (1990) (33)
N70 and P100 can be independently affected in multiple sclerosis. (1991) (32)
Parkinson's disease and nonmotor dysfunction (2005) (32)
The avascular zone and neuronal remodeling of the fovea in Parkinson disease (2015) (31)
Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease (1995) (31)
Wavelet Transform of the EEG Reveals Differences in Low and High Gamma Responses to Elementary Visual Stimuli (2001) (31)
Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy. (1992) (29)
The effect of contrast and spatial frequency on the visual evoked potential of the hooded rat (2004) (28)
Cortical Functional Anatomy of Voluntary Saccades in Parkinson Disease (2008) (28)
Dopamine D2 receptor blockade alters the primary and cognitive components of visual evoked potentials in the monkey, Macaca fascicularis (1997) (27)
Perisaccadic Occipital EEG Changes Quantified with Wavelet Analysis (2002) (26)
The auditory P300 correlates with specific cognitive deficits in Parkinson's disease (1990) (25)
Responses of complex cells in the visual cortex of the cat as a function of the length of moving slits (1976) (25)
Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease (2014) (24)
Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson's disease. (2002) (24)
Binocular stimulation reveals cortical components of the human visual evoked potential. (1981) (23)
Nicotinic receptors and cognition in Parkinson’s Disease: the importance of neuronal synchrony (2004) (23)
Electrophysiological evidence for visuocognitive dysfunction in younger non caucasian patients with Parkinson's disease (2005) (23)
Parkinson's disease changes the balance of onset and offset visual responses: an evoked potential study (2001) (23)
Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease (2005) (23)
Electrophysiological and psychophysical testing of vision in glaucoma. (1989) (22)
Electrophysiological evidence that early glaucoma affects foveal vision (1987) (22)
Cortical contrast gain control in human spatial vision. (1988) (22)
Visual and visual cognitive dysfunction in Parkinson's disease: spatial and chromatic vision. (1999) (22)
A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography (2015) (21)
On the possible role of temporal delays of afferent processing in Parkinson's disease. (1983) (21)
Visual evoked potentials in Parkinson's disease: spatial frequency, temporal rate, contrast, and the effect of dopaminergic drugs (1986) (21)
Nonmotor functions of the basal ganglia. (1984) (21)
Fovea and foveation in Parkinson's disease. (2013) (20)
The hemispheric distribution of the transient rat VEP: a comparison of flash and pattern stimulation (2004) (19)
Electrophysiological evidence for interhemispheric transmission of visual information in man. (1989) (19)
Visual 'cognitive' evoked potentials in the behaving monkey. (1991) (19)
The visuo-cognitive and motor effect of amantadine in non-Caucasian patients with Parkinson's disease. A clinical and electrophysiological study (2002) (19)
The Topography of the N70 Component of the Visual Evoked Potential in Humans (1989) (18)
Pattern visual evoked potentials in the rat (1982) (18)
Methodology of patterned stimulation. Chapter 1 in: Visual Evoked Potentials in Man: New Developments. (1977) (18)
Different spatial organizations of saccade related BOLD-activation in parietal and striate cortex (2008) (17)
Delayed visual evoked potentials are independent of pattern orientation in macular disease. (1987) (17)
Overview of Contrast Sensitivity and Neuro-ophthalmic Disease (1990) (16)
Visualizing the next steps in Parkinson disease. (2002) (16)
Getting around and communicating with the environment: visual cognition and language in Parkinson's disease. (2006) (16)
VISUAL ACUITY MEASUREMENTS WITH GRATING PATTERNS (1975) (16)
Systemic haloperidol administration increases the amplitude of the light- and dark-adapted flash ERG in the monkey (1989) (16)
Autonomic and electrocardiographic findings in Parkinson's disease (2017) (16)
Role of the calcarine cortex (V1) in perception of visual cues for saccades (2006) (15)
Activity engagement and health quality of life in people with Parkinson’s disease (2015) (15)
Sensory evoked potentials: PERG, VEP, and SEP. (1992) (15)
Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey (1994) (14)
Generator sources of SEP in man (1986) (14)
Perisaccadic Parietal and Occipital Gamma Power in Light and in Complete Darkness (2008) (14)
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations (1999) (14)
Grating Acuity in Two Sisters with Tapetoretinal Degeneration (1977) (14)
Dissociated sensory loss and visual evoked potentials in a patient with pernicious anemia. (1980) (13)
Abnormalities of the Visual System in Ocular Hypertension and Glaucoma: Seeing Beyond Routine Perimetry (1983) (13)
Pre-Emptive Perception (2008) (13)
Visual and visual perceptual disorders in neurodegenerative diseases. (1993) (13)
Hidden visual loss in optic neuropathy is revealed using Gabor patch contrast perimetry. (1997) (13)
The pattern ERG and VEP in glaucomatous optic nerve disease in the monkey and human (1986) (12)
Evidence for two distinct nonlinear components in the human pattern ERG (1992) (12)
Charles Bonnet Syndrome (1996) (12)
Pattern evoked potential changes in Parkinson's disease are stimulus‐dependent (1985) (11)
Conjugate eye movements and gamma power modulation of the EEG in persistent vegetative state (2006) (11)
Cortical control of saccades in Parkinson disease and essential tremor (2012) (10)
Evidence for two systems mediating perceived contrast (1991) (10)
A method of testing and evaluating blurred vision in cerebral lesions. (1973) (10)
Effect of levo-acetylcarnitine on P300-like potentials of the normal monkey. (1987) (10)
D1 agonist CY208–243 attenuates the pattern electroretinogram to low spatial frequency stimuli in the monkey (1998) (9)
Identification of Multiple Sources in Transient Visual Evoked Neuromagnetic Responses (1989) (9)
On the functional significance of primate retinal dopamine receptors. (1995) (9)
The effect of levo-acetyl-carnitine on visual cognitive evoked potentials in the behaving monkey. (1993) (9)
Physiological effects of acetyl-levo-carnitine in the central nervous system. (1990) (9)
Scalp distribution of pattern visual evoked potentials in normal and hemianopic monkeys (1987) (8)
Visuocognitive Dysfunctions in Parkinson’s Disease (2004) (8)
Push-Pull Model of Dopamine’s Action in the Retina (2002) (8)
Contrast Sensitivity and Increment Threshold (1972) (8)
Parkinson's Disease, Aging, and Visual Cognition (2008) (7)
ROUNDTABLE SESSION: THE TRUE BINOCULAR VISUAL EVOKED POTENTIAL: INTRODUCTION (1980) (7)
Vision and Visual Discrimination Suffer in Parkinson’s Disease: Evoked Potential Evidence (1991) (7)
Perisaccadic Gamma Modulation in Parkinson Disease Patients and Healthy Subjects (2010) (7)
Perception of Phosphenes and Flashed Alphabetical Characters is Enhanced by Single-Pulse Transcranial Magnetic Stimulation of Anterior Frontal Lobe: The Thalamic Gate Hypothesis (2008) (7)
Methodological Aspects of Contrast Sensitivity Measurements in the Diagnosis of Optic Neuropathy and Maculopathy (1983) (7)
Parkinson's disease severity and use of dopaminergic medications. (2015) (7)
The paracentral visual field in multiple sclerosis: evidence for a deficit in interneuronal spatial summation? (2001) (7)
Cortical control of voluntary saccades in Parkinson's disease and pre-emptive perception. (2012) (7)
Visual evoked potential latencies in papilledema and hydrocephalus (1981) (6)
The effect of refractive error on pattern electroretinograms in primates. (1986) (6)
Contrast sensitivity testing. (1984) (6)
STIMULUS PARAMETERS AND VISUAL EVOKED POTENTIAL DIAGNOSIS (1980) (5)
Contrast sensitivity in PD (1992) (5)
14 – NORMAL AND ABNORMAL MECHANISMS OF VISION: Visual Disorders and Visual Deprivation (1990) (5)
Critical Analysis of Pattern Evoked Potential Recording Techniques (1989) (5)
Electrophysiological assessment of retinal dopaminergic deficiency. (1996) (5)
Cortical control of voluntary saccades in Parkinson's Disease (2008) (5)
The dynamic effect of saccades in the visual cortex: evidence from fMRI, sTMS and EEG studies (2002) (5)
Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease (2015) (5)
The Effect of Diverse Dopamine Receptors on Spatial Processing in the Central Retina (2005) (5)
L-alpha-glycerylphosphorylcholine enhances the amplitude of the pattern electroretinogram in rhesus monkeys. A pilot study. (1999) (5)
The visual system in Parkinson's disease. (1990) (4)
Plasticity of monocular and binocular vision following cerebral blindness: evoked potential evidence. (1987) (4)
The effect of background spatial contrast on electroretinographic responses in the human retina (2009) (4)
Effect of L-acetyl carnitine HCl on rat steady-state visual evoked potentials. Comparison with L-carnitine. (1987) (4)
On dissociated visual functions. (1974) (4)
The auditory P 300 correlates with specific cognitive deficits in Parkinson's disease. (1990) (4)
High resolution cortical activation mapping of voluntary eye movements using functional magnetic resonance imaging. (1996) (4)
Primary Visual and Visuocognitive Deficits (2013) (3)
Research report Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson's disease (2002) (3)
Gamma-Band Modulation and Coherence in the EEG by Involuntary Eye Movements in Patients in Unresponsive Wakefulness Syndrome (2016) (3)
Annual Meeting, Association for Research in Nervous and Mental Diseases Inc: Vision and the Brain: The Organization of the Central Visual System (1987) (3)
Progress in retinal research, volume 3 (1985) (3)
Absence of somatosensory evoked potentials in patients with anosognosia (1977) (3)
Visual evoked potential latency changes and losses of grating pattern detection in multiple sclerosis. (1978) (3)
RECOVERY FROM CEREBRAL BLINDNESS: EVOKED POTENTIAL AND (1977) (2)
Topographical Analysis of the Onset VEP in the Detection of Paracentral Visual Field Defects (2002) (2)
Assessment of current visual psycho-physical testing methods with special reference to primary open angle glaucomatous disease (POAGD) (1994) (2)
Visual implications of diagnostic advances in neurology. (1979) (2)
CONTRAST SENSITIVITY IN PD. AUTHOR'S REPLY (1992) (2)
Saccades in the dark: fMRI evidence for separate cortical control of intentional eye movements (2002) (2)
Current Aspects of Cognitive Neurophysiology of Parkinson Disease: An Introduction (2010) (2)
Psychophysical examination of paracentral defects in glaucoma. (2000) (2)
Retinocortical Gain in the Foveal Pathway: The Effect of Spatial Frequency and Stimulus Size (2001) (2)
Perisaccadic V1 activity is not due to shifting visuo-spatial attention (2010) (2)
CHARLES BONNET SYNDROME. AUTHOR'S REPLY (1997) (1)
L-Acetylcarnetine prevents the parkinsonian syndrome induced by MPTP in monkeys (1987) (1)
Bode plots of cortical potentials evoked by dynamic random-dot correlograms (A) (1980) (1)
OCT in Parkinson’s Disease and Related Disorders (2020) (1)
P21.4 Gamma EEG in the evaluation of persistent vegetative state (2006) (1)
Transient visual evoked neuromagnetic responses: Identification of multiple sources (1989) (1)
OCT and Parkinson’s Disease (2016) (1)
5. Visual evoked potentials, contrast sensitivity and foveal optical coherence tomography in Parkinson’s disease patients (2016) (1)
PATTERN ELECTRORETINOGRAMS: GENERAL DISCUSSION (1980) (1)
Cognitive Neurophysiology of Parkinson Disease (2010) (1)
A Distractive Effect of Peripheral Attention on Foveal Trigram Recognition (1973) (1)
The wavelet transformed EEG: a new method of trial-by-trial evaluation of saccade-related cortical activity. (2006) (1)
Vision and neurodegenerative diseases. (1997) (1)
Chapter 25 Visual dysfunction in disorders with altered dopaminergic neurotransmission (2005) (1)
Impaired Dynamics of Retinal Processing in Dopaminergic Deficiency States in Man and Monkey (1995) (1)
Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview. (1993) (1)
The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease (2020) (1)
Special Issue: Pre-Emptive Perception (2008) (0)
The visual system, MBL lectures in biology, volume 5 (1986) (0)
WS-11-4 The electroretinogram in the evaluation of dopaminergic deficiency affecting the visual system: Parkinson's disease and the effects of drugs on the retina (1995) (0)
Interocular comparison ofcontrast sensitivities inglaucoma patients andsuspects (1980) (0)
The Re-Emergence of Systems Neuroscience (2001) (0)
How the size of the stimulus determines simultaneous PERG and VEP responses: What you gain and what you lose in the transit (1997) (0)
S40-5 Perisaccadic modulation of brain activity: EEG and fMRI (2010) (0)
INTRODUCTION (1980) (0)
GENERAL DISCUSSION (1980) (0)
Annual Meeting, Association for Research in Nervous and Mental Diseases Inc: Immunologic Mechanisms in Neurologic and Psychiatric Disease (1988) (0)
Optic nerve disease: an introduction. (1997) (0)
Functional Aspects of Paracentral Vision (1993) (0)
The clinical use of multichannel VEP recordings in detecting visual field defects (1993) (0)
Clinical aspects: Parkinson’s disease (1995) (0)
Imaging the Retinopathy of Parkinson's Disease (2008) (0)
The visual system in Parkinson's disease. (1987) (0)
Workshop Visual evoked potentialsAbnormal contrast-dependent VEP changes in Parkinson's disease (1985) (0)
IFOND SPONSORED INTERNATIONAL FIELD INVESTIGATION OF A 300 MEMBER PEDIGREE WITH LHON IN BRAZIL.: 8:45 - 9:00 (2002) (0)
Decreased Contrast Sensitivity and inner retinal thinning of the fovea in Parkinson Disease (2013) (0)
Clinical neuroscience: Introduction (1998) (0)
Pre-emptive perception. Introduction. (2008) (0)
WS7-1 Saccade-related cortical activity (2010) (0)
The Role of Visual Perception in Spoken Responses (2011) (0)
Visual evoked potential diagnosis offield defects in patients withchiasmatic andretrochiasmatic lesions (1982) (0)
INTRODUCTION (1982) (0)
PATTERN ELECTRORETINOGRAMS: GENERAL DISCUSSION (1982) (0)
Differences in perisaccadic retinotopic and spatiotopic localization in the parietal and occipital cortices in the absence of visual input (2010) (0)
Visual and cognitive ERPs in trained monkeys (1990) (0)
2.2.2 FRONTO-PARIETAL COHERENCE AND IMPAIRED VOLUNTARY SACCADES IN PARKINSON DISEASE (PD) (2012) (0)
3. Perisaccadic EEG components in Parkinson disease patients (2013) (0)
ROUNDTABLE SESSION: THE TRUE BINOCULAR VISUAL EVOKED POTENTIAL: INTRODUCTION (1980) (0)
The diagnostic significance of the topography of N70 of the VEP (1990) (0)
Retinal periphlebitis in multiple sclerosis. (1993) (0)
Asymmetry of the retina in the two eyes in Parkinson Disease (2013) (0)
Beyond Classical Retinotopy: Striate Cortical Mechanisms Associated with Voluntary Saccades and Attention (2002) (0)
Stimulus specific VEP lateralization in normals and patients with hemianopias (1985) (0)
VISUAL FUNCTION IMPROVEMENT WITH EXPERIMENTAL THERAPY IN MITOCHON DRIAL OPTIC NEUROPATHY: Poster # 59 (OD-120) (1994) (0)
Comorbidities Prove Challenging In The Identification Of Parkinson Disease Patients And Normal Controls For PD Retinal Model Development (2012) (0)
Letter: Visual acuity measurements with grating patterns. (1975) (0)
SYSTEM DISEASES AND VISUAL EVOKED POTENTIAL DIAGNOSIS IN NEUROLOGY: CHANGES DUE TO SYNAPTIC MALFUNCTION * (1980) (0)
Early Detection of Paracentral Defects: Implications for Neuroprotection in Primary Open-Angle Glaucoma (1999) (0)
Cognitive Deficits in Neurodegenerative Disorders: Parkinson’s Disease and Alzheimer’s Disease (2011) (0)
STIMULUS PARAMETERS AND VISUAL EVOKED POTENTIAL DIAGNOSIS (1980) (0)
Syphilitic perioptic neuritis in an HIV-seropositive patient: A case report and VEP study (1995) (0)
GENERAL DISCUSSION (1982) (0)
Editors note: The above letter was referred to the authors of the original paper, and their reply follows (1997) (0)

This paper list is powered by the following services:

Ivan G. Bodis-wollner's Academic­Influence.com Rankings

Ivan G. Bodis-wollner's Degrees

Why Is Ivan G. Bodis-wollner Influential?

Ivan G. Bodis-wollner's Published Works

Published Works

Ivan G. Bodis-wollner's AcademicInfluence.com Rankings